Psychosis Archives - Page 2 of 18

Addiction

Illicit Amphetamine Use May Increase Risk for Psychosis

February 23, 2022

Illicit amphetamine use is associated with an increased incidence of psychosis.

General Psychiatry

The Effectiveness of Mental Health Training of Primary Care Providers Using an Antistigma Intervention

By

Mary Stroka

February 8, 2022

This study looked at the mental health training of primary care practitioners and an antistigma intervention for people with lived experience of mental illness.

Schizophrenia and Psychoses

Patterns of Perceptual Processing Among Patients With Schizophrenia or Schizoaffective Disorder

By

Jessica Nye

January 12, 2022

In a study, perceptual updating was assessed via a random dot motion perception task. Midway through the test, the motion direction changed. Study participants were then asked to report the direction.

Neurodevelopmental Disorder

The Association Between School Absenteeism With Mental Disorders and Self-Harm

By

Jessica Nye

December 21, 2021

Researchers examined nationwide data from the Welsh Demographic Service Dataset to determine if absence and exclusion from school were associated with a record of neurodevelopmental disorder, mental disorder, and self-harm.

Alzheimer Disease and Dementia

Hallucinations May Be Charles Bonnet Syndrome, Not Early Dementia

By

K. Patricia Bouweraerts, MA

September 21, 2021

In a 10-year follow-up of AREDS 2 participants, symptoms of CBS were associated with late AMD and cataract surgery, but normal cognition.

Alzheimer Disease and Dementia

Sustained Response to Pimavanserin Reduces Relapse Risk in Patients With Dementia-Related Psychosis

By

Jessica Nye, PhD

September 14, 2021

Can the continuation of pimavanserin help with managing dementia-related psychosis? Researchers report on the findings of the phase 3 HARMONY trial.

Schizophrenia and Psychoses

PsyMetRiC: a Metabolic Risk Calculator for Young Patients With Psychosis

By

Jessica Nye, PhD

July 1, 2021

Individuals with psychotic disorders have a 10 to 15 year shorter life span compared with the general population, mostly due to physical conditions like obesity, cardiovascular disease, and type 2 diabetes. A cardiometabolic risk prediction algorithm can offer informed treatment decisions in order to prevent long-term cardiometabolic outcomes.

An increased risk for the development of psychiatric disorders such as schizophrenia and social anxiety disorder has been found with the use of cannabis; depression to a lesser extent. Individuals who are heavy cannabis users are more likely to report suicidal thoughts than non-users. For patients with bipolar disorder, near-daily cannabis use seemed to increase symptoms of the disorder. However, for patients with schizophrenia or other psychoses, a history of cannabis use has been associated with better performance on learning and memory tasks.

Child/Adolescent Psychiatry

Factors ID’d for Pediatric Involuntary Psychiatric Hospitalization

May 19, 2021

Children and adolescents with involuntary psychiatric hospitalization are more likely to have a diagnosis of psychosis, substance misuse, or intellectual disability than those admitted voluntarily.

APA 2021

Dementia-Related Psychosis and Off-Label Use of Atypical Antipsychotics

By

Psychiatry Advisor Contributing Writer

May 5, 2021

With atypical antipsychotics (AAPs) being prescribed off-label for treating dementia-related psychosis, the study authors evaluated the comparative efficacy, safety, and effectiveness of AAPS by conducting a network meta-analysis.